Blockade of interleukin-6 as a possible therapeutic target for AA amyloidosis
AA (secondary) amyloidosis is a severe complication of chronic inflammatory disorders. It is characterized by the systemic deposition of an abnormal protein called amyloid, affecting mainly renal function. IL-6 is a cytokine with a relevant role in this disease development. Interleukin-receptor anta...
Gespeichert in:
Veröffentlicht in: | Nefrología 2022-01 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng ; spa |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!